Top

Rheumatology International

Published in:

01-01-2021 | Colchicine | Observational Research

Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study

Authors: Emin Murat Karpuzoglu, Rabia Miray Kisla Ekinci, Sibel Balci, Atil Bisgin, Mustafa Yilmaz

Published in: Rheumatology International | Issue 1/2021

Abstract

Objectives

Familial Mediterranean Fever (FMF) is the most common hereditary autoinflammatory disorder characterized by recurrent fever and serositis episodes. Identification of low penetrant or heterozygous MEFV mutations in clinically diagnosed FMF patients did raise a concern on whether epigenetic or environmental factors play an additional role in FMF pathogenesis. We aimed to investigate the expression profile of apoptosis-related miRNAs in FMF and their influence on clinical manifestations in the present study.

Method

191 pediatric FMF patients and 31 healthy children included in the study. Expressions of 33 apoptosis-related, circulating cell-free miRNAs were evaluated by a quantitative polymerase chain reaction, statistically calculated within ΔΔCt values and fold changes were evaluated by Welch T test, in which p < 0.05 were considered to be significant.

Results

Nineteen miRNAs, including let-7a-5p, let-7c, let-7 g-5p, miR-15b-5p, miR-16-5p, miR-17-5p, miR-23a-3p, miR-24-3p, miR-25-3p, miR-26a-5p, miR-26b-5p, miR-27a-3p, miR-29c-3p, miR-30a-5p, miR-30d-5p, miR-30e-5p, miR-106b-5p, miR-146a-5p, and miR-195-5p, were found down-regulated; miR-15a-5p, miR-29b-3p, miR-181a-5p, miR-181b-5p, miR-181c-5p, miR-214-3p, and miR-365a-3p were up-regulated in FMF patients. In detail, these miRNAs were similar among FMF patients in terms of genotype, colchicine response, and having an inflammatory attack during analysis.

Conclusion

We found that 26 apoptosis-related circulating miRNAs were deregulated in children with FMF. Thus, we speculate that these miRNAs have a role in FMF pathogenesis via apoptotic mechanisms.

Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the world. Arthritis Rheum 61:1447–1453. https://doi.org/10.1002/art.24458CrossRefPubMed

Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84(1):11. https://doi.org/10.1097/01.md.0000152370.84628.0cCrossRef

Kisla Ekinci RM, Balci S, Dogruel D, Altintas DU, Yilmaz M (2019) Twenty-year experience of a single referral center on pediatric familial Mediterranean fever: what has changed over the last decade? J Clin Rheumatol. https://doi.org/10.1097/RHU.0000000000001146CrossRef

Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, Amselem S, Gershoni-Baruch R, Touitou I, Ben-Chetrit E (2013) Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum 43:387–391. https://doi.org/10.1016/j.semarthrit.2013.04.011CrossRefPubMed

Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz C (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53:741–745. https://doi.org/10.1093/rheumatology/ket400CrossRef

Ait-Idir D, Djerdjouri B, Bouldjennet F, Taha RZ, El-Shanti H, Sari-Hamidou R, Khellaf G, Benmansour M, Benabadji M, Haddoum F (2017) The M694I/M694I genotype: a genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever. Eur J Med Genet 60:149–153. https://doi.org/10.1016/j.ejmg.2016.12.003CrossRefPubMed

The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807. https://doi.org/10.1016/s0092-8674(00)80539-5CrossRef

French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31. https://doi.org/10.1038/ng0997-25CrossRef

Manukyan G, Aminov R (2016) Update on pyrin functions and mechanisms of familial Mediterranean fever. Front Microbiol 7:456. https://doi.org/10.3389/fmicb.2016.00456CrossRefPubMedPubMedCentral

10.

Álvarez-Errico D, Vento-Tormo R, Ballestar E (2017) Genetic and epigenetic determinants in autoinflammatory diseases. Front Immunol 8:318. https://doi.org/10.3389/fimmu.2017.00318CrossRefPubMedPubMedCentral

11.

Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854. https://doi.org/10.1016/0092-8674(93)90529-yCrossRefPubMed

12.

Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901–906. https://doi.org/10.1038/35002607CrossRefPubMed

13.

Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH (2019) An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234:5451–5465. https://doi.org/10.1002/jcp.27486CrossRefPubMed

14.

Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355. https://doi.org/10.1038/nature02871CrossRefPubMed

15.

Latsoudis H, Mashreghi MF, Grün JR, Chang HD, Stuhlmüller B, Repa A, Gergiannaki I, Kabouraki E, Vlachos GS, Häupl T, Radbruch A, Sidiropoulos P, Doukoumetzidis K, Kardassis D, Niewold TB, Boumpas DT, Goulielmos GN (2017) Differential expression of miR-4520a associated with pyrin mutations in familial Mediterranean fever (FMF). J Cell Physiol 232:1326–1336. https://doi.org/10.1002/jcp.25602CrossRefPubMed

16.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A (2018) MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway. Rheumatology (Oxford) 57:718–726. https://doi.org/10.1093/rheumatology/kex451CrossRef

17.

Wada T, Toma T, Matsuda Y, Yachie A, Itami S, Taguchi YH, Murakami Y (2017) Microarray analysis of circulating microRNAs in familial Mediterranean fever. Mod Rheumatol 27:1040–1046. https://doi.org/10.1080/14397595.2017.1285845CrossRefPubMed

18.

Akkaya-Ulum YZ, Balci-Peynircioglu B, Karadag O, Eroglu FK, Kalyoncu U, Kiraz S, Ertenli AI, Özen S, Yilmaz E (2017) Alteration of the microRNA expression profile in familial Mediterranean fever patients. Clin Exp Rheumatol 35(Suppl 108):90–94PubMed

19.

Hortu HO, Karaca E, Sozeri B, Gulez N, Makay B, Gunduz C, Atik T, Tekin IM, Unsal SE, Cogulu O (2019) Evaluation of the effects of miRNAs in familial Mediterranean fever. Clin Rheumatol 38(3):635–643. https://doi.org/10.1007/s10067-017-3914-0CrossRefPubMed

20.

Amarilyo G, Pillar N, Ben-Zvi I, Weissglas-Volkov D, Zalcman J, Harel L, Livneh A, Shomron N (2018) Analysis of microRNAs in familial Mediterranean fever. PLoS ONE 13:e0197829. https://doi.org/10.1371/journal.pone.0197829CrossRefPubMedPubMedCentral

21.

Demir F, Çebi AH, Kalyoncu M (2020) Assessment of circulating microribonucleic acids in patients with familial Mediterranean fever. Arch Rheumatol. https://doi.org/10.5606/ArchRheumatol.2020.7414CrossRefPubMed

22.

de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823–874. https://doi.org/10.1146/annurev-immunol-032414-112227CrossRefPubMedPubMedCentral

23.

Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17:914–921. https://doi.org/10.1038/ni.3457CrossRefPubMedPubMedCentral

24.

Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong YN, Peng X, Xi JJ, Chen S, Wang F, Shao F (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 513:237–241. https://doi.org/10.1038/nature13449CrossRefPubMed

25.

Martinon F, Hofmann K, Tschopp J (2001) The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 11:118–120. https://doi.org/10.1016/s0960-9822(01)00056-2CrossRef

26.

Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A, Gumucio DL (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 276:39320–39329. https://doi.org/10.1074/jbc.M104730200CrossRefPubMed

27.

Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, Schaller M, Cesena T (2002) Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 20:45–53

28.

Kashyap D, Tuli HS, Garg VK, Goel N, Bishayee A (2018) Oncogenic and tumor-suppressive roles of MicroRNAs with special reference to apoptosis: molecular mechanisms and therapeutic potential. Mol Diagn Ther 22:179–201. https://doi.org/10.1007/s40291-018-0316-1CrossRefPubMed

29.

Pathak S, McDermott M, Savic S (2016) Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol 70:1–8. https://doi.org/10.1136/jclinpath-2016-203810CrossRefPubMed

30.

Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651. https://doi.org/10.1136/annrheumdis-2015-208690CrossRefPubMed

31.

Huang Z, Xu Y, Peng W (2015) Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol Med Rep 12:5939–5944. https://doi.org/10.3892/mmr.2015.4222CrossRefPubMed

32.

Chen XM, Liu J, Wang T, Shang J (2012) Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways. Toxicol In Vitro 26:649–655. https://doi.org/10.1016/j.tiv.2012.01.024CrossRefPubMed

33.

Balci-Peynircioglu B, Akkaya-Ulum YZ, Akbaba TH, Tavukcuoglu Z (2019) Potential of miRNAs to predict and treat inflammation from the perspective of familial Mediterranean fever. Inflamm Res 68:905–913. https://doi.org/10.1007/s00011-019-01272-6CrossRefPubMed

34.

Siegel RM, Fleisher TA (1999) The role of Fas and related death receptors in autoimmune and other disease states. J Allergy Clin Immunol 103:729–738. https://doi.org/10.1016/s0091-6749(99)70412-4CrossRefPubMed

35.

Shiohara M, Taniguchi S, Masumoto J, Yasui K, Koike K, Komiyama A, Sagara J (2002) ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 293:1314–1318. https://doi.org/10.1016/S0006-291X(02)00384-4CrossRefPubMed

36.

Ozen S, Uckan D, Baskin E, Besbas N, Okur H, Saatci U, Bakkaloglu A (2001) Increased neutrophil apoptosis during attacks of familial Mediterranean fever. Clin Exp Rheumatol 19:68–71

37.

Ceri M, Unverdi S, Senes M, Altay M, Yilmaz R, Yucel D, Duranay M (2013) Serum soluble fas ligand levels in familial Mediterranean fever. Ren Fail 35:835–857. https://doi.org/10.3109/0886022X.2013.794660CrossRefPubMed

38.

Davtyan TK, Harutyunyan VA, Hakobyan GS, Avetisyan SA (2008) Heightened endotoxin susceptibility of monocytes and neutrophils during familial Mediterranean fever. FEMS Immunol Med Microbiol 52:370–378. https://doi.org/10.1111/j.1574-695X.2008.00385.xCrossRefPubMed

39.

Manukyan G, Aminov R, Hakobyan G, Davtyan T (2015) Accelerated apoptosis of neutrophils in familial Mediterranean fever. Front Immunol 6:239. https://doi.org/10.3389/fimmu.2015.00239CrossRefPubMedPubMedCentral

40.

Liu B, Guo Z, Gao W (2019) miR-181b-5p promotes proliferation and inhibits apoptosis of hypertrophic scar fibroblasts through regulating the MEK/ERK/p21 pathway. Exp Ther Med 17:1537–1544. https://doi.org/10.3892/etm.2019.7159CrossRefPubMedPubMedCentral

41.

Wang X, Li Z, Bai J, Song W, Zhang F (2019) miR-17-5p regulates the proliferation and apoptosis of human trabecular meshwork cells by targeting phosphatase and tensin homolog. Mol Med Rep 19:3132–3138. https://doi.org/10.3892/mmr.2019.9973CrossRefPubMedPubMedCentral

42.

Sárközy M, Kahán Z, Csont T (2018) A myriad of roles of miR-25 in health and disease. Oncotarget 9:21580–21612. https://doi.org/10.18632/oncotarget.24662CrossRefPubMedPubMedCentral

43.

Zheng C, Zheng Z, Sun J, Zhang Y, Wei C, Ke X, Liu Y, Deng L, Wang H (2017) MiR-16-5p mediates a positive feedback loop in EV71-induced apoptosis and suppresses virus replication. Sci Rep 7:16422. https://doi.org/10.1038/s41598-017-16616-7CrossRefPubMedPubMedCentral

44.

Zhao DL, Wu QL (2019) Effect of inhibition to Yes-related proteins-mediated Wnt/β-catenin signaling pathway through miR-195-5p on apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci 23:6486–6496. https://doi.org/10.26355/eurrev_201908_18532CrossRefPubMed

Title: Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study
Authors: Emin Murat Karpuzoglu
Rabia Miray Kisla Ekinci
Sibel Balci
Atil Bisgin
Mustafa Yilmaz
Publication date: 01-01-2021
Publisher: Springer Berlin Heidelberg
Keywords: Colchicine
Familial Mediterranean Fever
Published in: Rheumatology International / Issue 1/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04541-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study

Abstract

Objectives

Method

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

COVID-19 in Italian Sjögren's syndrome patients: a monocentric study

Trends in psoriatic arthritis epidemiology in Poland

Response to ‘How to define disease severity accurately in patients with familial Mediterranean fever’

Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review

Inflammatory milieu of muscle biopsies in juvenile dermatomyositis

Patients’ beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page